The effect of neuropeptide Y on mucociliary activity in the rabbit maxillary sinus

Acta Otolaryngol. 1991;111(5):960-6. doi: 10.3109/00016489109138437.

Abstract

The effect of neuropeptide Y (NPY) on mucociliary activity in the rabbit maxillary sinus was investigated in vivo by injecting NPY at increasing dosages into the maxillary artery, response being recorded photoelectrically. At dosages of 0.1-5.0 micrograms/kg, NPY reduced mucociliary activity dose-dependently, the maximum decrease being 14.6 +/- 1.8%, at a dosage of 5.0 micrograms/kg. The NPY-induced reduction of the mucociliary activity manifested brief latency, the peak effect occurring within 3 min followed by a slow return to the baseline value 4-9 min after injection. The response of mucociliary activity to NPY remained unaffected by pretreatment with the alpha-adrenergic antagonists yohimbine (alpha 2) at 100.0 micrograms/kg and phentolamine (alpha 1 + alpha 2) at 0.2-1.0 mg/kg, indicating that the effect of NPY is not mediated via alpha-receptors. Pretreatment with the calcium antagonist nifedipine at 100.0 micrograms/kg inhibited the effect of NPY, suggesting that the NPY-induced decrease may be calcium dependent.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic alpha-Antagonists / pharmacology
  • Animals
  • Cilia / physiology
  • Dose-Response Relationship, Drug
  • Female
  • Male
  • Maxillary Sinus / drug effects
  • Maxillary Sinus / physiology*
  • Mucous Membrane / drug effects
  • Mucous Membrane / physiology
  • Neuropeptide Y / antagonists & inhibitors
  • Neuropeptide Y / pharmacology*
  • Nifedipine / pharmacology
  • Rabbits

Substances

  • Adrenergic alpha-Antagonists
  • Neuropeptide Y
  • Nifedipine